DIALysis With EXpanded Solute Removal
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4800 participants.
Also called NCT06660277
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 4,800 participants
- Sponsor
- Registry
-
NCT06660277
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT06660277. Randomized; no masking; primary purpose treatment. Start 2025-08-12 (actual); primary completion 2031-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DIALysis With EXpanded Solute Removal
- Acronym
- DIALEX
- Condition
- Chronic Kidney Disease Requiring Hemodialysis
- Condition
- End-Stage Kidney Disease (ESKD)
- Condition
- Chronic Kidney Disease Requiring Chronic Dialysis
- Condition
- Pragmatic Randomized Controlled Trial
- Condition
- Kidney Disease
- Condition
- Renal Insufficiency, Chronic
- Condition
- Kidney Failure, Chronic
- Condition
- Hemodialysis
- Intervention (Device)
- Super High-Flux Dialyzer
- Intervention (Device)
- High-Flux Dialyzer
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Collaborator
- Schulich School of Medicine and Dentistry
- Collaborator
- ICES
- Collaborator
- Nipro Canada Corporation
- Collaborator
- London Health Sciences Centre
- Collaborator
- Statistics Canada
Record details
- Record id
cardio:ct-nct06660277- Content hash
042f7dc4a1e284f89417b7462b6477f4795642918dd012a4c41c270f595685d4